Citius Pharmaceuticals
CTXR
CTXR
56 hedge funds and large institutions have $18.9M invested in Citius Pharmaceuticals in 2022 Q3 according to their latest regulatory filings, with 12 funds opening new positions, 7 increasing their positions, 12 reducing their positions, and 16 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
less ownership
Funds ownership: →
less funds holding
Funds holding: →
25% less first-time investments, than exits
New positions opened: 12 | Existing positions closed: 16
42% less repeat investments, than reductions
Existing positions increased: 7 | Existing positions reduced: 12
Holders
56
Holding in Top 10
–
Calls
$1.43M
Puts
$108K
Top Buyers
| 1 | +$2.28M | |
| 2 | +$171K | |
| 3 | +$108K | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$96.3K |
| 5 |
TSS
Two Sigma Securities
New York
|
+$56K |
Top Sellers
| 1 | -$1.16M | |
| 2 | -$203K | |
| 3 | -$157K | |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$146K |
| 5 |
E
Ergoteles
New York
|
-$86.9K |